Wendy Ross, MD, FAAP

Director of Jefferson Center for Autism and Neurodiversity, Jefferson Health

Wendy J. Ross, MD, FAAP is a developmental and behavioral pediatrician and the inaugural director of the Jefferson Center for Autism and Neurodiversity where she creates community opportunities. She was a top ten CNN hero in 2014 for her work on community participation. Dr. Ross attended the humanities and medicine program at Mt Sinai, pediatrics residency at Yale, and fellowship in developmental pediatrics at Harvard.

Cindy Hou, DO, MA, MBA, FACOI, FACP, FIDSA

Infection Control Officer, Jefferson Health-New Jersey

Cindy Hou, DO, is the Infection Control Officer and infectious diseases specialist at Jefferson Health New Jersey. Her hospital system was nationally recognized by Sepsis Alliance as a Sepsis Hero in 2016. She is the physician lead for the hospital’s Antimicrobial Stewardship Committee, Sepsis on the Floors Task Force, Infection Control Committee, and more. Dr. Hou has been a passionate advocate for early detection, prevention, education, and management of sepsis in the community hospital setting. She has helped to champion the development of nurse-initiated policies, old school education, and the impact of multi-disciplinary teams on survival of patients with sepsis. She has also studied the impact of mandatory infectious disease consults on C. Diff infections and severe sepsis. She also serves as the physician champion for the NJHA’s Antimicrobial Stewardship Collaborative. In 2018, she was a recipient of Heroes of Infection Prevention Award in Patient Safety from APIC. She is also on the Sepsis Alliance Advisory Board of Directors.

Jonathan L. Gleason, MD

Chief Clinical Officer, Executive Vice President, Prisma Health

Dr. Jonathan L. Gleason is a renowned thought leader and healthcare executive. He has served in executive roles at several of America’s most notable clinically integrated health systems – Carilion Clinic, Jefferson Health, and Prisma Health. Dr. Gleason currently serves as executive vice president, Chief Clinical Officer for Prisma Health with broad responsibilities for the clinical and academic mission of the $5bn, 18-hospital clinical integrated health system. His work to build clinical operating systems that are elite partners to people has achieved remarkable results inside of traditional health systems as well as in the business community. Dr. Gleason’s work has been recognized by multiple national awards for innovation in care delivery and safety, and his insights on these topic are in high demand in publications such as the New England Journal, the World Economic Forum and the Wall Street Journal. Dr. Gleason is also a researcher and advocate for people with disabilities and his landmark publication in the New England Journal of Medicine Catalyst about the impact of COVID-19 on individuals with intellectual disabilities resulted in global changes to vaccine prioritization. Dr. Gleason serves on advisory committees for Special Olympics International, and he serves on the board of Special Olympics Pennsylvania.